181 results on '"Sabate, Raimon"'
Search Results
2. Probing Alzheimer's pathology: Exploring the next generation of FDDNP analogues for amyloid β detection
3. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease
4. Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease
5. Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease
6. Coumarin derivatives against amyloid-beta 40 – 42 peptide and tau protein
7. Piano-stool metal complexes as inhibitors of amyloid-β aggregation in vitro and in vivo.
8. Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau
9. From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
10. In Vivo Assays for Amyloid-Related Diseases
11. Proximity-Induced Pharmacology for Amyloid-Related Diseases
12. Anti-Amyloid Drug Screening Methods Using Bacterial Inclusion Bodies
13. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease
14. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors
15. Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics
16. Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects
17. New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer's disease.
18. Investigation into the stability and reactivity of the pentacyclic alkaloid dehydroevodiamine and the benz-analog thereof
19. Identification of a novel cell death-inducing domain reveals that fungal amyloid-controlled programmed cell death is related to necroptosis
20. Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics.
21. Predicting the aggregation propensity of prion sequences
22. Shogaol–huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties
23. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies
24. Preparation and characterization of extruded magnetoliposomes
25. Protein folding and aggregation in bacteria
26. Amyloids in bacterial inclusion bodies
27. Air Curtains Equipped With Hydroalcoholic Aerosol Sprayers for Massive COVID-19 Disinfection
28. Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis Regulation
29. Biological role of bacterial inclusion bodies: a model for amyloid aggregation
30. Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
31. Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer’s disease
32. Spontaneous incorporation of β-amyloid peptide into neutral liposomes
33. Synthesis, in vitro profiling, and in vivo efficacy studies of a new family of multitarget antiAlzheimer compounds
34. Synthesis, in vitro profiling, and in vivo efficacy studies of a new family of multitarget anti-alzheimer compounds
35. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies
36. Synthesis, In Vitro Profiling, and In Vivo Efficacy Studies of a New Family of Multitarget Anti-Alzheimer Compounds
37. Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods
38. Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases
39. Evidence of the existence of micelles in the fibrillogenesis of beta-amyloid peptide
40. Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein–huprine hybrids
41. Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs
42. Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion
43. Could α-Synuclein Amyloid-Like Aggregates Trigger a Prionic Neuronal Invasion?
44. Determination of micellar microenvironment of pinacyanol by visible spectroscopy
45. Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases.
46. Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion
47. Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs
48. In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time
49. Amyloids in solid-state nuclear magnetic resonance: potential causes of the usually low resolution
50. Amyloids in solid-state nuclear magnetic resonance: potential causes of the usually low resolution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.